Objective | Outcome assessment | Tests conducted at |
Primary | ||
Assess postoperative function and mobility | The Oxford Hip Score (OHS) | 120 days after surgery |
Secondary | ||
Assess postoperative function and early mobility | The De Morton Mobility Index (DEMMI) test | 3 and 120 days after surgery |
The Cumulated Ambulation Score (CAS) | 3 days after surgery | |
Assess pain | Numeric Pain Rating Scale (NPRS) | 3 and 120 days after surgery |
Measure quality of life | EuroQol EQ-5D-5L | 120 days after surgery |
Assess analgesia medication use | Analgesia medication use recorded from patient notes | 3 and 120 days after surgery |
Measure hospital stay | Acute and total length of hospital stay | At time of discharge from acute and overallhospital stay |
Assess any negative consequences of care | Adverse events (AE) and serious adverse events (SAEs), defined as any negative consequence of care resulting in unintended injury or illness | Continually throughout study participation, on average 120 days |
Assess complication rates | Specific hip-related complications: dislocation, nerve injury, periprosthetic fracture, infection within 120 days of operation and need for re-operation (with reasons) | Within 120 days after surgery, recording the date of complication |
Record discharge destination | The percentage of participants who are discharged to their prefracture place of residence | At time of discharge from hospital admission |
Return to place of residence | Place of residence. The percentage of participants returning to their prefracture place of residence | At 120 days after surgery |
Estimate survival | Mortality within 120 days of the operation | Within 120 days after surgery, recording the date of death |